Zonghong Shao

机构：Second Hospital of Tianjin Medical University, Tianjin Medical University

发表论文 4 篇 · 总被引 36 次 · h-index 1

代表论文

• A new dosing regimen of ropeginterferon alfa-2b is highly effective and tolerable: findings from a phase 2 study in Chinese patients with polycythemia vera (2023 · Experimental Hematology and Oncology · 被引 34)
• Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms (2022 · Blood · 被引 1)
• Phase Ⅱ,Open-Label, Multicenter, Single-Arm Study Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Chinese Patients with Polycythemia Vera Resistant or Intolerant to Hydroxyurea(HU) (2022 · Blood · 被引 1)
• ASXL1 Is a Risk Factor for Thrombosis in Polycythemia Vera (2022 · Blood)